Related Experiment Video
Updated: Sep 18, 2025

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Optimizing Nephron Performance: The Old, the New, and the New-Old Diuretic Therapies
Flavio D Fuchs1,2, Guilherme S Procianoy1, Leonardo G Bottino1,2
1Division of Cardiology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-903, Brazil.
Insights
Diuretics, both old and new, effectively manage hypertension, heart failure, and chronic kidney disease (CKD). Recent evidence highlights the efficacy of older agents like chlorthalidone and acetazolamide, alongside newer drugs such as gliflozins.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Pharmacological interventions targeting nephron function significantly impact hypertension, heart failure, and chronic kidney disease (CKD).
- Diuretics represent a cornerstone therapy, with ongoing research exploring both established and novel agents.
Purpose of the Study:
- To review the efficacy of traditional and newer diuretics in managing hypertension, heart failure, and CKD.
- To highlight emerging evidence on the effectiveness of established diuretic agents.
Main Methods:
- Review of existing literature, including randomized controlled trials and nonrandomized studies.
- Analysis of data on thiazide, loop, potassium-sparing diuretics, indapamide, gliflozins, chlorthalidone, and acetazolamide.
Main Results:
- Established diuretics (thiazides, loop diuretics) show efficacy in heart failure and CKD, with randomized trials confirming their role in preventing cardiovascular disease.
- Potassium-sparing agents mitigate thiazide side effects and reduce cardiovascular events in heart failure.
- Newer agents like gliflozins offer novel mechanisms for managing heart failure and slowing CKD progression, irrespective of diabetes status.
- Recent studies demonstrate significant blood pressure reduction with chlorthalidone in advanced CKD and accelerated clinical control with acetazolamide in acute heart failure.
Conclusions:
- Both established and novel diuretics play crucial roles in managing cardiovascular and kidney diseases.
- Emerging evidence reinforces the value of older diuretic agents, while newer drugs offer distinct therapeutic advantages.
- Future research should explore combination therapies to optimize nephron function and patient outcomes.
Abstract:
Pharmacological influence on nephron function has modified the clinical course of hypertension, heart failure, and chronic kidney disease. (CKD). This is a review of the efficacy of old diuretics and the incremental efficacy of new diuretics in managing hypertension, heart failure, and CKD, concluding with new evidence on the effectiveness of old agents. The efficacy of "older" diuretic agents, such as thiazide and loop diuretics, on heart failure and CKD has been primarily explored in nonrandomized studies. However, the efficacy of these agents and indapamide, a slightly newer but still "old" diuretic in preventing blood pressure-related cardiovascular disease, has been demonstrated in randomized controlled trials. Potassium-sparing agents counteract some of the adverse effects of thiazides and have been shown to prevent cardiovascular events in patients with heart failure. Newer drugs with a diuretic effect, such as gliflozins, act through a new mechanism of action in the kidney and have shown efficacy in controlling symptoms and preventing cardiovascular events in patients with heart failure, regardless of diabetes. Furthermore, gliflozins have prevented the progression of chronic kidney disease in patients with and without diabetes mellitus. New evidence detailing the efficacy of old agents has emerged. Chlorthalidone had a large blood-pressure-lowering effect in patients with stage IV CKD. Acetazolamide was effective in accelerating the clinical control of patients with acute heart failure, including patients with some reduction in kidney function. We anticipate investigating the comparative impact of combining different agents to optimize nephron function in the future.
Related Concept Videos
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Physiology of the Genitourinary System III: Urine Concentration and Dilution

